SECreport

Form 4 RELMADA THERAPEUTICS, For: Jan 29 Filed by: TRAVERSA SERGIO

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com